There is no defined standard chemotherapy and there is currently no robust, prospective, randomized data to advise different use of specific chemotherapy agents in TNBC as compared to non-TNBC. Data suggest high sensitivity to chemotherapy, however it is yet to be determined whether this increased sensitivity is agent/regimen specific or whether it reflects general chemosensitivity.
Adjuvant systemic treatment for individual patients with triple negative breast cancer / Oakman C; Moretti E; Galardi F; Biagioni C; Santarpia L; Biganzoli L; Di Leo A. - In: THE BREAST. - ISSN 0960-9776. - ELETTRONICO. - (2011), pp. S135-S141.